MX1 and COVID-19: Studies performed during the first wave of the pandemic demonstrated that MxA detection has high sensitivity and negative predictive value for identifying patients with COVID-19.11–13 FebriDx is a low-cost, analyzer-free, easy-to-use PoCT device that returns results in 10 minutes.